Press Release


Legend Capital Portfolio Company Yonz Technology Lists on the Main Board of the Shanghai Stock Exchange
Jul 05, 2024 18:41 JST
On June 26, Legend Capital's portfolio company, Yonz Technology Co., Ltd. (603381.SH), was successfully listed on the Main Board of the Shanghai Stock Exchange.
More info..

Legend Capital's Portfolio Company Aidite Lists on the ChiNext Successfully
Jun 27, 2024 11:48 JST
On June 26, Legend Capital's portfolio company, Aidite (301580.SZ), was successfully listed on the ChiNext of the Shenzhen Stock Exchange.
More info..

Legend Capital Portfolio Company Qunabox Group Lists on the Main Board of the HKEX Successfully
May 29, 2024 10:38 JST
On May 27, Legend Capital?s portfolio company, Qunabox Group (0917.HK), was successfully listed on the main board of the Hong Kong Stock Exchange with an opening price of HKD33 per share, a 32% increase from the issue price of HKD25 per share.
More info..

Legend Capital Portfolio Company ZKH Lists on the New York Stock Exchange Successfully
Dec 19, 2023 15:45 JST
On the evening of December 15th, Beijing time, Legend Capital's portfolio company, ZKH Group Limited ("ZKH") (NYSE: ZKH), was officially listed on the New York Stock Exchange.
More info..

Co-led by Legend Capital, Leadrive Completes Series D Financing Round
Oct 10, 2023 13:55 JST
On October 9th, Leadrive Technology ("Leadrive") announced the completion of its Series D financing round, with an amount of over RMB600 million.
More info..

Legend Capital Portfolio Company TUHU Car Lists on the Main Board of the HKEX Successfully
Sep 27, 2023 15:19 JST
On September 26, Legend Capital's portfolio company, TUHU Car (9690.HK), was successfully listed on the main board of the Hong Kong Stock Exchange.
More info..

Legend Capital Portfolio: Nuclei, the World's First RISC-V CPU IP Vendor, Accomplishes ISO 26262 ASIL-D Product Certificate
Aug 18, 2023 20:09 JST
Legend Capital's portfolio company, Nuclei System Technology, a leading RISC-V CPU IP vendor in China, announces that NA900 has been certified to be compliant with ASIL D requirements of ISO 26262 standards for both systematic fault and random hardware fault. NA900 becomes the world's first RISC-V CPU IP achieving ISO 26262 ASIL D product certificate.
More info..

Backed by Legend Capital, the Chinese Pet Food Industry Leader Gambol Pet Goes Public Successfully
Aug 18, 2023 16:43 JST
On August 16, Legend Capital's portfolio company, Gambol Pet (301498.SZ), was successfully listed on the ChiNext Market of the Shenzhen Stock Exchange. Gambol Pet plans to issue 40,004,500 shares at an offering price of RMB39.99 per share, with an estimated total fundraising of approximately RMB1.6 billion.
More info..

Exploring New Collaborative Opportunities! The Indonesia-China Healthcare and Biotech Investment Forum Successfully Held
Jul 31, 2023 19:48 JST
On 27 July 2023, on the eve of the highly anticipated Chengdu FISU World University Games, the Minister of Health Indonesia Budi Gunadi Sadikin accompanied Indonesian President Joko Widodo on a visit to China.
More info..

One More IPO of Legend Capital: Medical Device Supply Chain Service Provider GKHT Medical Goes Public Successfully
Jul 14, 2023 16:17 JST
On July 12, Legend Capital's portfolio company, GKHT Medical Technology Co., Ltd. ("GKHT Medical"; Stock Code: 301370.SZ), was successfully listed on the ChiNext Market of the Shenzhen Stock Exchange.
More info..

Empowering R&D in Special Diseases, "Next Generation" CRO Company TriApex Completes Series C with Hundreds of Millions of CNY, Led by Legend Capital
May 04, 2023 16:15 JST
TriApex Laboratories Co., Ltd (hereinafter referred to as "TriApex") recently announced the completion of its Series C financing round, which was led by Legend Capital.
More info..

Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia
Mar 31, 2023 09:28 JST
On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint venture to develop and commercialize toripalimab in Thailand, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Vietnam[1].
More info..

Led by Legend Capital, Macrolux Completes Nearly CNY100 million Series A Round
Feb 16, 2023 17:09 JST
Shenzhen Macrolux Medical Technology Co., Ltd. (hereinafter referred to as "Macrolux") recently announced the completion of its Series A round by securing nearly CNY100 million, which is led by Legend Capital.
More info..

Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital
Feb 15, 2023 18:58 JST
Legend Capital invested in 29 healthcare companies that officially disclosed financing rounds in 2022, according to the VBDATA Database.
More info..

Legend Capital Portfolio Company Bespin Global Completes USD100m Series D Financing
Dec 15, 2022 12:30 JST
Legend Capital Portfolio Company Bespin Global, a Korea-headquartered cloud services company, has recently completed its Series D round financing of USD100 million, which will be used mostly for acquisitions.
More info..

Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing
Dec 09, 2022 19:27 JST
Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as "GS Biotech") officially announced the completion of its nearly CNY100 million pre-A round financing, led by Legend Capital.
More info..

Legend Capital Portfolio Company Atour Successfully Lists on Nasdaq
Nov 13, 2022 10:12 JST
On the evening of November 11, Beijing time, Legend Capital portfolio company Atour Lifestyle Holdings Limited ("Atour") was officially listed on the Nasdaq Stock Exchange in the United States. It has priced its initial public offering of 4,750,000 American Depositary Shares ("ADSs") at US$11.0 per ADS.
More info..

Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round
Nov 10, 2022 14:26 JST
Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as "PureFDA") announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital.
More info..

Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX
Nov 07, 2022 15:49 JST
On November 4, 2022, Legend Capital portfolio company Giant Biogene (2367.HK) was successfully listed on the main board of the Hong Kong Stock Exchange.
More info..

Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round
Nov 01, 2022 18:05 JST
Recently, the healthcare big data leader ClinBrain completed the Series C round of financing of nearly CNY200 million, led by Legend Capital.
More info..

Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round
Nov 01, 2022 17:51 JST
Shanghai Easy-Flow ("Easy-Flow") recently completed its Angel financing round by raising tens of millions of CNY, led by Legend Capital. The fresh capital will be used for the R&D of Easy-Flow's peripheral intervention pipeline.
More info..

Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round
Oct 20, 2022 14:45 JST
VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as "VectorBuilder"), a top gene delivery enterprise, recently announced the completion of its Series C round with CNY410 million, co-led by Legend Capital.
More info..

GalaxySpace Completes a New Financing Round with Legend Capital Re-upped
Sep 25, 2022 10:56 JST
GalaxySpace, a Chinese commercial aerospace company, recently completed its latest financing round with a post-investment valuation of approximately RMB11 billion.
More info..

Leadrive Technology Completes Series C Financing, Legend Capital Re-upped
Sep 25, 2022 10:47 JST
Leadrive Technology, a leading supplier of power semiconductor and motor control solutions for new energy vehicles, recently announced its completion of the series C financing. As the existing shareholder, Legend Capital continued to support this round of financing.
More info..

Legend Capital: The Logic of Technology Investment Has Changed
Sep 02, 2022 17:05 JST
Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit on the KOSDAQ market on 21 July 2022.
More info..

Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY
Aug 19, 2022 17:55 JST
Shanghai Applied Protein Technology Co., Ltd. ("APTBIO"), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital.
More info..

Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully
Aug 15, 2022 16:50 JST
On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext of Shenzhen Stock Exchange.
More info..

Legend Capital Super Antibiotic Portfolio Company: Scarce Enterprise MicuRx Pharmaceuticals is Listed on the STAR Market Successfully
Aug 09, 2022 13:06 JST
On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on the STAR Market.
More info..

New Power to Legend Capital Carbon Neutral Investment Portfolio: Ruicycle Raises Over RMB 300 Million from Series B
Aug 08, 2022 13:46 JST
Shenzhen Ruicycle Environmental Protection Technology Co., Ltd (also known as Hengchuang Ruineng), a battery recycling company, recently accomplished the B round of fundraising with over RMB 300 million, which is backed by Legend Capital.
More info..

Latest Release


More Latest Release >>